Table 5.
Binary logistic regression analyses exploring association of different serum levels of HBV-DNA with total diabetes, FPG ≥7mmol/L and HbA1c ≥6.5% (unadjusted OR with 95% CI).
| p-value OR (95%CI) |
Serum HBV-DNA: ≥ 20000 IU/mL |
Serum HBV-DNA: ≥ 2000, <20000 IU/mL |
Serum HBV-DNA: ≥ 100, <2000 IU/mL |
Serum HBV-DNA: <100 IU/mL |
|---|---|---|---|---|
| Total diabetes | ||||
| Serum HBV-DNA: ≥20000 IU/mL |
– | P<0.001 1.39 (1.18-1.64) |
P=0.084 1.13 (0.98-1.29) |
P=0.060 1.12 (1.00-1.26) |
| Serum HBV-DNA: ≥2000, <20000 IU/mL |
P<0.001 0.72 (0.61-0.85) |
– | P=0.015 0.81 (0.69-0.96) |
P=0.006 0.81 (0.69-0.94) |
| Serum HBV-DNA: ≥100, <2000 IU/mL |
P=0.084 0.89 (0.77-1.02) |
P=0.015 1.23 (1.04-1.46) |
– | P=0.921 0.99 (0.88-1.12) |
| Serum HBV-DNA: <100 IU/mL |
P=0.060 0.89 (0.79-1.01) |
P=0.006 1.24 (1.06-1.45) |
P=0.921 1.01 (0.89-1.14) |
– |
| FPG ≥7mmol/L | ||||
| Serum HBV-DNA: ≥20000 IU/mL |
– | P=0.001 1.39 (1.14-1.69) |
P=0.004 1.27 (1.08-1.49) |
P=0.001 1.28 (1.11-1.47) |
| Serum HBV-DNA: ≥2000, <20000 IU/mL |
P=0.001 0.72 (0.59-0.87) |
– | P=0.360 0.91 (0.74-1.11) |
P=0.370 0.92 (0.76-1.10) |
| Serum HBV-DNA: ≥100, <2000 IU/mL |
P=0.004 0.79 (0.67-0.93) |
P=0.360 1.10 (0.90-1.34) |
– | P=0.897 1.01 (0.87-1.17) |
| Serum HBV-DNA: <100 IU/mL |
P=0.001 0.78 (0.68-0.90) |
P=0.370 1.09 (0.91-1.31) |
P=0.897 0.99 (0.85-1.15) |
– |
| HbA1c ≥6.5% | ||||
| Serum HBV-DNA: ≥20000 IU/mL |
– | P=0.012 1.57 (1.10-2.24) |
P=0.001 1.68 (1.24-2.27) |
P<0.001 1.66 (1.26-2.17) |
| Serum HBV-DNA: ≥2000, <20000 IU/mL |
P=0.012 0.64 (0.45-0.91) |
– | P=0.712 1.07 (0.75-1.51) |
P=0.753 1.05 (0.76-1.45) |
| Serum HBV-DNA: ≥100, <2000 IU/mL |
P=0.001 0.60 (0.44-0.80) |
P=0.712 0.94 (0.66-1.33) |
– | P=0.917 0.99 (0.76-1.28) |
| Serum HBV-DNA: <100 IU/mL |
P<0.001 0.60 (0.46-0.79) |
P=0.753 0.95 (0.69-1.31) |
P=0.917 1.01 (0.78-1.32) |
– |
CI, Confidence Interval; DNA, Deoxyribonucleic Acid; FPG, Fasting Plasma Glucose; HbA1c, Glycated Hemoglobin; HBV, Hepatitis B Virus; OR, Odds Ratio.